1. Neuroprotective effect of Naochuxue prescription on intracerebral hemorrhage: inhibition of autophagy downregulating high mobility group box-1.
- Author
-
Hong J, Xinna W, Ruonan W, Jinjian LI, Junchao YU, Dexi Z, and Lu Z
- Subjects
- Animals, Rats, Male, Humans, Down-Regulation drug effects, Interleukin-6 genetics, Interleukin-6 metabolism, Toll-Like Receptor 4 genetics, Toll-Like Receptor 4 metabolism, Beclin-1 genetics, Beclin-1 metabolism, Rats, Sprague-Dawley, Cerebral Hemorrhage drug therapy, Cerebral Hemorrhage metabolism, Cerebral Hemorrhage genetics, Neuroprotective Agents administration & dosage, Neuroprotective Agents pharmacology, Autophagy drug effects, HMGB1 Protein genetics, HMGB1 Protein metabolism, Drugs, Chinese Herbal administration & dosage, Drugs, Chinese Herbal pharmacology
- Abstract
Objective: To determine the molecular mechanisms underlying the neuroprotective effects of Naochuxue prescription (,NCXP) in rats with intracerebral hemorrhage (ICH)., Methods: Sprague-Dawley rats were injected with collagenase to generate ICH models, which were then randomly divided into six groups, including control, sham, model, and three intervention groups. The intervention groups received different doses of NCXP (0.13, 0.26, and 0.52 g/kg) daily for 10 d. High-performance liquid chromatography (HPLC) was used to analyze the chemical characteristics of NCXP. The neurobehavioral outcomes of the rats were evaluated using neurological deficit scores (Zea Longa 5) and the corner turn test. Pathomorphological changes in perihematomal tissues after ICH were observed using hematoxylin and eosin staining. Immunohistochemistry (IHC) was used to detect the inflammation expression of interleukin 6 (IL-6) and toll-like receptor 4 (TLR4). High mobility group box-1 (HMGB1), Beclin1, microtubule-associated protein 1 light chain 3 beta (LC3), and sequestosome 1 (p62) were detected using real-time quantitative polymerase chain reaction and Western blotting in perihematomal tissues., Results: HPLC showed that the NCXP had good stability. Rats with ICH had severe neurological function deficits compared to the control group. IHC results showed that NCXP significantly downregulated the expression of the inflammatory proteins IL-6 and TLR4. ICH rats treated with NCXP showed less neurological injury than the model group, accompanied by a significantly decreased expression of HMGB1, Beclin1, and LC3 and an increased expression of p62., Conclusions: The neuroprotective effect of NCXP alleviated inflammation and autophagy possibly by downregulating HMGB1 expression. However, further research on the signaling pathways is required to verify this hypothesis.
- Published
- 2024
- Full Text
- View/download PDF